Promising clinical outcomes of sequential and "Sandwich" chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I E /II E extranodal natural killer/T-cell lymphoma.

MLA

Wang, Han-Yu, et al. “Promising Clinical Outcomes of Sequential and ‘Sandwich’ Chemotherapy and Extended Involved-Field Intensity-Modulated Radiotherapy in Patients with Stage I E /II E Extranodal Natural Killer/T-Cell Lymphoma.” Cancer Medicine, vol. 7, no. 12, Dec. 2018, pp. 5863–69. EBSCOhost, https://doi.org/10.1002/cam4.1755.

APA

Wang, H.-Y., Niu, S.-Q., Yang, Y.-Y., Li, Y.-Y., Chen, H.-B., & Zhang, Y.-J. (2018). Promising clinical outcomes of sequential and “Sandwich” chemotherapy and extended involved-field intensity-modulated radiotherapy in patients with stage I E /II E extranodal natural killer/T-cell lymphoma. Cancer Medicine, 7(12), 5863–5869. https://doi.org/10.1002/cam4.1755

Chicago

Wang, Han-Yu, Shao-Qing Niu, Yun-Ying Yang, Yi-Yang Li, Hong-Bo Chen, and Yu-Jing Zhang. 2018. “Promising Clinical Outcomes of Sequential and ‘Sandwich’ Chemotherapy and Extended Involved-Field Intensity-Modulated Radiotherapy in Patients with Stage I E /II E Extranodal Natural Killer/T-Cell Lymphoma.” Cancer Medicine 7 (12): 5863–69. doi:10.1002/cam4.1755.